Allonnia develops biotechnological solutions to remediate emerging contaminants such as PFAS and 1,4-dioxane using proprietary microbial systems and innovative separation technologies. Their methods enable the detoxification of contaminated water, aiming to treat over 600 billion gallons by 2040 while enhancing sustainable practices in the metals and mining industries.

Bonsai Robotics provides a connected autonomy platform designed to bring automation to field and factory operations. This platform enables humans and machines to work smarter together across various demanding environments. The company focuses on making autonomy simple, affordable, and deployable across entire off-road equipment fleets.

Cadstrom offers an automated validation platform that analyzes PCB schematics, component datasheets, and SPICE simulations to detect thousands of electrical issues that manual checklists often miss. By delivering deterministic, human‑readable reports based on industry best‑practice rules, it integrates with existing EDA tools to speed up design reviews, cut costly respins, and give hardware teams confidence in their releases.

This company develops collaborative robots designed for intuitive, reactive interaction within human workspaces. Their platform integrates advanced intelligence into their cobot hardware, enabling seamless integration into existing manufacturing or assembly processes. The core offering focuses on providing adaptable automation solutions that enhance operational flexibility and worker collaboration.

Cosmo provides personalized, live 1-on-1 tutoring for K12 students in ELA and Math, integrating certified teachers with AI tools. The platform uses adaptive assessments to create dynamic learning plans and offers 24/7 homework support to ensure continuous academic growth. Students receive structured instruction and interactive practice tailored to their specific knowledge gaps.

Frontera Health develops AI-powered tools to assist physicians in evaluating and treating children with autism and related neurodevelopmental disorders. Their platform aims to improve access to and quality of autism care in underserved regions.

InnerPlant develops genetically engineered crops that emit optical signals to indicate stress from pathogens, nutrient deficiencies, or drought. This technology enables farmers to receive real-time, actionable insights, enhancing agricultural productivity and sustainability while reducing reliance on pesticides and waste.

Juvena Therapeutics utilizes an AI-driven platform to identify and engineer secreted proteins into biologic therapeutics that restore tissue homeostasis. The company addresses the dysregulation of protein signaling that leads to degenerative diseases, including myopathies and metabolic disorders.

Passkey Therapeutics utilizes its Locksmith® platform, which employs AI-enhanced computational genetics, to identify synergistic pairs of biological pathways for therapeutic intervention. This technology enables the development of novel drug combinations and multifunctional drugs targeting complex diseases. The company focuses on creating a new class of synergistic therapies by moving beyond the single-target drug development paradigm.

Sourcewater provides a comprehensive database of water sources, reuse, and disposal options for the upstream energy sector, utilizing patented satellite imagery and AI analytics to track water logistics and drilling activities. This platform enables energy companies to optimize water sourcing and disposal, reducing operational costs and improving efficiency in water management.

Teal provides a modular API and front-end code snippets that enable SMB software companies to integrate accounting products directly into their platforms, creating a centralized financial operating system for their customers. This solution allows businesses to access critical financial insights and automate accounting tasks, enhancing customer engagement and retention.

This company develops artificial intelligence research and products focused on making AI systems more widely understood and customizable. They build multimodal AI systems designed for human-AI collaboration, pushing frontier capabilities in areas like science and programming. The firm emphasizes sharing research and building reliable infrastructure to maximize productivity and security in AI development.

Vivodyne provides a preclinical platform that utilizes lab-grown human organ tissue models for drug discovery and development. This platform enables high-throughput testing on thousands of human tissues to generate predictive human data before clinical trials. The resulting multimodal datasets power advanced AI models to refine new therapeutic targets and optimize drug candidates.

Zyphra is developing a full-stack artificial general intelligence (AGI) platform that integrates advanced machine learning algorithms to enhance decision-making processes across various industries. The technology addresses the limitations of narrow AI by providing adaptable, human-like reasoning capabilities, enabling organizations to optimize operations and improve outcomes.